Is IL-6 a key cytokine target for therapy in COVID-19?
Nat Rev Immunol
; 21(6): 337-339, 2021 06.
Article
in English
| MEDLINE | ID: covidwho-1182836
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Interleukin-6
/
Cytokine Release Syndrome
/
SARS-CoV-2
/
COVID-19
/
COVID-19 Drug Treatment
Type of study:
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Nat Rev Immunol
Journal subject:
Allergy and Immunology
Year:
2021
Document Type:
Article
Affiliation country:
S41577-021-00553-8
Similar
MEDLINE
...
LILACS
LIS